Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BAPTA

Copy Product Info
😃Good
Catalog No. T7098Cas No. 85233-19-8

BAPTA is a neuroprotective agent in cerebral ischemia, acting as an intercellular Ca2+ chelator.

BAPTA

BAPTA

Copy Product Info
😃Good
Purity: 97.21%
Catalog No. T7098Cas No. 85233-19-8
BAPTA is a neuroprotective agent in cerebral ischemia, acting as an intercellular Ca2+ chelator.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
50 mg$33In StockIn Stock
100 mg$50In StockIn Stock
500 mg$90-In Stock
1 mL x 10 mM (in DMSO)$52In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.21%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

BAPTA AI Summary
BAPTA has shown bioactivity as an inhibitor in two different assays: it inhibits Tyrosyl-DNA Phosphodiesterase (TDP1) with a potency of 1995.3 nM and inhibits Fructose-1,6-bisphosphate Aldolase from Giardia lamblia with a potency of 3971.6 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
BAPTA is a neuroprotective agent in cerebral ischemia, acting as an intercellular Ca2+ chelator.
Chemical Properties
Molecular Weight476.43
FormulaC22H24N2O10
Cas No.85233-19-8
SmilesOC(=O)CN(CC(O)=O)c1ccccc1OCCOc1ccccc1N(CC(O)=O)CC(O)=O
Relative Density.1.494 g/cm3
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility Information
DMSO: 83 mg/mL (174.21 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2 mg/mL (4.2 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0989 mL10.4947 mL20.9894 mL104.9472 mL
5 mM0.4198 mL2.0989 mL4.1979 mL20.9894 mL
10 mM0.2099 mL1.0495 mL2.0989 mL10.4947 mL
20 mM0.1049 mL0.5247 mL1.0495 mL5.2474 mL
50 mM0.0420 mL0.2099 mL0.4198 mL2.0989 mL
100 mM0.0210 mL0.1049 mL0.2099 mL1.0495 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BAPTA | purchase BAPTA | BAPTA cost | order BAPTA | BAPTA chemical structure | BAPTA formula | BAPTA molecular weight